Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Cytomegaloviral Infection: early-phase trial registry

2 of 4 indexed Cytomegaloviral Infection trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Cytomegaloviral Infection: 4 US clinical trials tracked, 2 recruiting.

Cytomegaloviral Infection is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is City of Hope Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition cytomegaloviral-infection

OPEN 2 | RECR 50% | LATE 0 | EARLY 4 | RANK #4115 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cytomegaloviral Infectio (th…50%
Open-enrollment share among volume-matched conditions near Cytomegaloviral Infection

Cytomegaloviral Infection lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cytomegaloviral Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cytomegaloviral Infection is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 12Phase 22

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Named interventions

Most-linked intervention names on Cytomegaloviral Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Multi-peptide CMV-Modified Vaccinia Ankara Vaccine Biological
2 trials
Laboratory Biomarker Analysis Other
2 trials
Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes Biological
1 trials
Virus-specific Cytotoxic T-lymphocytes Biological
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Cytomegaloviral Infection trials. A trial with sites in several states counts in each.

Texas 3 trials
California 2 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cytomegaloviral Infection page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cytomegaloviral Infection condition card totals 4 registered trials; most-linked intervention Multi-peptide CMV-Modified Vaccinia Ankara Vaccine; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.